JD
Chief of Staff
RP
Chief Medical & Scientific Officer
Get the full picture
Sign in to uncover key details.
OS Therapies
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
115 Pullman Crossing Rd Ste 103, Grasonv...Phone Number
(410) 297-7793Website
www.ostherapies.comRevenue
-Stock Symbol
OSTXIndustry
About OS Therapies
OS Therapies is a clinical-stage biotechnology company focused on developing novel immunotherapies for osteosarcoma and other solid tumors. Its lead platform OST-HER2 aims to activate immune responses against HER2-expressing cancers, while its second platform OST-tADC is an antibody-drug conjugate system designed to deliver targeted cancer-killing payloads with reduced toxicity. The company is advancing clinical trials for osteosarcoma and expanding into breast, lung, and other solid tumors.Explore more
OS Therapies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to OS Therapies
Compare insights from companies similar to OS Therapies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OS Therapies Tech Stack
A closer look at the technologies used by OS Therapies
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OS Therapies
Sign Up For FreeTo access detailed company insights
OS Therapies is a clinical-stage biotechnology company focused on developing novel immunotherapies for osteosarcoma and other solid tumors. Its lead platform OST-HER2 aims to activate immune responses against HER2-expressing cancers, while its second platform OST-tADC is an antibody-drug conjugate system designed to deliver targeted cancer-killing... Read More
